Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Major depression (MD) and anorexia nervosa (AN) often present comorbidly and both share some affective symptoms, despite obvious phenotypic differences. In the illness phase, pathophysiological evidence indicates similar abnormalities in both clinical groups including dysfunction in the serotonin (5-HT) system (of which some abnormalities persist following recovery) and between 60% and 80% of patients in both groups present with significant hyperactivity of the hypothalamo-pituitary-adrenal (HPA) axis. First-line approach to treatment for MD involves modulation of the 5-HT system using selective serotonin reuptake inhibitors (SSRIs). For AN, treatment with SSRIs has been shown to be considerably less effective compared to MD. Both illnesses show marked dysregulation in the HPA axis. A consequence of SSRI treatment is a reduction and/or normalization of indices of the HPA axis [i.e. cortisol, adrenocorticotropic hormone (ACTH)], which is consistent with recovery levels in both clinical groups. Oestrogen (in high doses) has been shown to exert antidepressant effects and positively impact on MD symptoms as a treatment in its own right, or in combination with antidepressants, in women of menopausal age. It is proposed that a combination of SSRIs and oestrogen therapy may facilitate physiological normalization in MD in women of non-menopausal age and in AN. Preliminary evidence suggests oestrogen treatment alone is of some benefit to patients and it is proposed that a combination of SSRI and oestrogen will precipitate and potentially accelerate symptomatic remission. Should this approach be successful, it offers the capacity for improvement over traditional antidepressant use in women diagnosed with MD and a novel strategy for the treatment of AN, a serious clinical illness associated with the highest mortality of any psychiatric condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Puberty and depression: the roles of age, pubertal status and pubertal timing.
ANGOLD, A., COSTELLO, E. J., & WORTHMAN, C. M. (1998) · Psychological Medicine · doi:10.1017/s003329179700593x · Cited by 989
Mortality in anorexia nervosa.
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.1073 · Cited by 974 · cited 2×
“AN presents with the greatest risk of mortality of any psychiatric condition, up to 20% (Sullivan, 1995) and many (y50%) remain in a chronic relapsing cycle (Kaye et al.”
BackgroundNew insights into symptoms and neurocircuit function of anorexia nervosa
Kaye, W. H., Fudge, J. L., & Paulus, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2682 · Cited by 843 · cited 6×
“Some patients from each clinical group have responded to antidepressants ; however, efficacy, particularly in AN, is contentious, despite relatively greater success in preventing relapse (Kaye et al. 2009).”
BackgroundInfluentialZobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585
Neuroendocrine aspects of hypercortisolism in major depression
Parker, K. J., Schatzberg, A. F., & Lyons, D. M. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(02)00016-8 · Cited by 455 · cited 3×
“Parker et al. (2003) have further disseminated physiological state linked to MD, suggesting that although patients with acute and chronic MD tend to present with hypercortisolism, sustained impact of illness leads to HPA axis changes, as distinct from acute experiences (Parker et al.”
BackgroundAnorexia Nervosa and Major Depression: Shared Genetic and Environmental Risk Factors
Wade, T. D., Bulik, C. M., Neale, M., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.469 · Cited by 375 · cited 4×
“MD and AN often present comorbidly in patients (Wade et al. 2000), and both are more prevalent in females ; MD presents twice as often (Burt & Quezada, 2009 ; Doris et al.”
BackgroundInfluential
Cited by
The chronic mild stress (CMS) model of depression: History, evaluation and usage
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.002 · Cited by 959
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Sex and gender differences in trauma victims presenting for treatment
Christiansen, D. M. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00043-7 · Cited by 9
Trauma and gender in primary care
Christiansen, D. M. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00043-2 · Cited by 3
Metadata
- Authors
- Keating, C., Tilbrook, A., & Kulkarni, J.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-22
- Volume
- 14
- Issue
- 04
- Pages
- 553-566
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2199941754
- Cited by
- 23
- References
- 21
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? https://app.cochat.ai/papers/10.1017/s1461145710000982
- The paper
- Keating, C., Tilbrook, A., & Kulkarni, J. (2011). Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response? The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145710000982
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.